Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in LondonBeth Russell, Mieke Van Hemelrijck, Charlotte Moss et al.|Frontiers in Oncology|2020Cited by 64
Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in LondonBeth Russell, Kavita Raj, Charlotte Moss et al.|British Journal of Cancer|2021Cited by 59
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)Eleni Josephides, Eleni Karapanagiotou, Ana Montes et al.|Clinical Lung Cancer|2025Cited by 5
Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.Danielle Crawley, Sharmistha Ghosh, Kerri Beckmann et al.|Journal of Clinical Oncology|2020Cited by 1
Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 deathMaria J. Monroy‐Iglesias, Saoirse Dolly, Beth Russell et al.|Clinical Cancer Research|2021Cited by 0